Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA)

Karin E Finberg, Matthew M Heeney, Dean R Campagna, Yeşim Aydinok, Howard A Pearson, Kip R Hartman, Mary M Mayo, Stewart M Samuel, John J Strouse, Kyriacos Markianos, Nancy C Andrews, Mark D Fleming

Research output: Contribution to journalArticlepeer-review

600 Scopus citations

Abstract

Iron deficiency is usually attributed to chronic blood loss or inadequate dietary intake. Here, we show that iron deficiency anemia refractory to oral iron therapy can be caused by germline mutations in TMPRSS6, which encodes a type II transmembrane serine protease produced by the liver that regulates the expression of the systemic iron regulatory hormone hepcidin. These findings demonstrate that TMPRSS6 is essential for normal systemic iron homeostasis in humans.

Original languageEnglish
Pages (from-to)569-71
Number of pages3
JournalNature Genetics
Volume40
Issue number5
DOIs
StatePublished - May 2008

Keywords

  • Adolescent
  • Anemia, Iron-Deficiency/drug therapy
  • Child
  • Child, Preschool
  • Female
  • Germ-Line Mutation
  • Homeostasis/genetics
  • Humans
  • Infant
  • Iron/metabolism
  • Male
  • Membrane Proteins/genetics
  • Protein Structure, Tertiary/genetics
  • Serine Endopeptidases/genetics

Cite this